Assessing Diaphragm Activity and Breathing Mechanics During NAVA Ventilation
Official title: Evaluation of the Relationship Between Electrical Activity of the Diaphragm and Respiratory Mechanics During Neurally Adjusted Ventilatory Assist in Lung Transplant Patients and in Patients Affected by Acute Respiratory Failure.
Run by University of Padova · NCT05689476 · Data updated 2026-11-12
This study is testing if a special type of breathing support called NAVA can help lung transplant patients breathe better and protect their lungs while they recover in the ICU.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Padova Academic / other |
| Locations | 1 site (Padova, Italy) |
| Status | Recruiting |
| Started | December 27, 2022 |
| Main results expected | December 27, 2025 |
| Study ends | December 27, 2025 |
| Registry record updated | July 8, 2025 |
| Trial ID | NCT05689476 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are admitted to the ICU for monitoring after lung transplantation and exhibit spontaneous breathing activity.
✕Probably not a fit
Patients with severe hemodynamic instability or contraindications to nasogastric tube insertion may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of Neurally Adjusted Ventilatory Assist (NAVA) in patients who have undergone lung transplantation. It focuses on the relationship between the electrical activity of the diaphragm and various respiratory parameters, such as tidal volume and driving pressure, during different levels of ventilatory support. The goal is to understand how NAVA can reduce ventilator-induced lung injury and diaphragm dysfunction in the early postoperative period. Participants will be monitored in the ICU to assess their spontaneous breathing activity and response to NAVA.
Why it matters
Potential benefit: If successful, this approach could significantly improve respiratory outcomes and reduce complications for lung transplant patients.
How similar studies have gone: While the use of NAVA is established, this specific evaluation of its effects post-lung transplantation is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 y.o. * Admission to ICU for post-operative monitoring after LTx or acute respiratory failure needing invasive mechanical ventilation * Presence of spontaneous breathing activity * Sedation titrated to a target RASS between 0 and -2 * Written informed consent obtained Exclusion Criteria: * Contraindication to nasogastric tube insertion (gastroesophageal surgery in the previous 3 months, gastroesophageal bleeding in the previous 30 days, history of esophageal varices, facial trauma) * Increased risk of bleeding with nasogastric tube insertion, due to severe coagulation disorders and severe thrombocytopenia ( i.e., INR \> 2 and platelets count \< 70.000/mm3) * Severe hemodynamic instability (noradenaline \> 0.3 μg/kg/min and/or use of vasopressin) * Postoperative extracorporeal respiratory support (ECMO) * Pre-operative reconditioning of the transplanted lungs by means of ex-vivo lung perfusion (EVLP) * Lung retransplantation * Failure to obtain a stable EAdi signal
Where it's running
-
Institute of Anaesthesia and Intensive Care, Padua University hospital
Padova, Italy, Italy Recruiting
Study contacts
- Study coordinator: Annalisa Boscolo, MD
- Email: annalisa.boscolobozza@aopd.veneto.it
- Phone: +390498213090
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Muscle health before and after lung transplant in adults
This study tests how respiratory and leg muscle health relates to physical function and recovery in adults awaiting and after lung transplantation.
-
Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency
This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.
-
How different ventilator settings affect lung energy during gallbladder surgery
This study tests whether two ventilator modes (VCV and PRVC) deliver different amounts of energy to the lungs in adults undergoing laparoscopic gallbladder removal.
-
Weaning HFNC: When to Stop High-Flow Oxygen in Acute Respiratory Failure
This study tests a protocol to guide when to stop high-flow nasal therapy in adults with acute respiratory failure who are already on HFNC.
-
Height measurement methods to guide ventilator settings in ARDS
We’re testing whether more precise height measurements change how researchers set lung-protective tidal volumes in adults with ARDS who are on a ventilator.
-
Heliox to ease breathing and sharpen thinking when breathing is hard
This trial will test whether breathing heliox (a low-density gas mix) reduces breathing effort and improves reaction time and accuracy in healthy adults exposed to increased inspiratory resistance.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.